Cost Efficacy and Challenges of Real-world Brolucizumab use for Neovascular AMD

被引:0
|
作者
Sharma, Kayshaliya [1 ,2 ]
Rave, Vanessa [1 ,2 ]
Wagner, Alan [1 ]
Kapoor, Kapil [1 ]
机构
[1] Wagner Kapoor Res Inst, Norfolk, VA USA
[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
432
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Real-world analysis of brolucizumab in neovascular AMD
    Rave, Vanessa
    Sharma, Kayshaliya
    Wagner, Alan
    Kapoor, Kapil
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [2] Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study
    Aziz, Aamir
    Khanani, Arshad
    London, Nikolas
    Hagen, Molly
    Danzig, Carl
    Kulkarni, Amol
    Sheth, Veeral
    Jhaveri, Chirag
    Eichenbaum, David
    Singer, Michael
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [3] Therapy for AMD: real-world data on the safety of brolucizumab
    Bitzer, Michaela
    [J]. AUGENHEILKUNDE UP2DATE, 2023, 13 (01) : 5 - 6
  • [4] Real-world efficacy and safety of brolucizumab
    Walter, Scott
    Saba, Nicholas
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [5] Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study
    Bulirsch, Louisa Maria
    Sassmannshausen, Marlene
    Nadal, Jennifer
    Liegl, Raffael
    Thiele, Sarah
    Holz, Frank G.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (09) : 1288 - 1294
  • [6] Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
    Mehta, Hemal
    Kim, Leah N.
    Mathis, Thibaud
    Zalmay, Pardis
    Ghanchi, Faruque
    Amoaku, Winfried M.
    Kodjikian, Laurent
    [J]. CLINICAL OPHTHALMOLOGY, 2020, 14 : 3331 - 3342
  • [7] Real-World Use of Off-Label MVASI in the Treatment of Patients With Neovascular AMD and DME
    Lombardo, Marco
    Missiroli, Filippo
    Cerri, Luca
    Sorge, Roberto P.
    Cesareo, Massimo
    Ricci, Federico
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (07):
  • [8] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kwon, Hye Ji
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Hoseok Yeom
    Hye Ji Kwon
    Yoon Jeon Kim
    Junyeop Lee
    Young Hee Yoon
    Joo Yong Lee
    [J]. Scientific Reports, 13